Novartis Oncology President David Epstein: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Novartis’ oncology chief discusses in-licensing candidates, as well as how biologics fit into the firm’s oncology pipeline.
Novartis’ oncology chief discusses in-licensing candidates, as well as how biologics fit into the firm’s oncology pipeline.